Trials / Conditions / Relapsed or Refractory Large B-cell Lymphoma
Relapsed or Refractory Large B-cell Lymphoma
3 registered clinical trials studyying Relapsed or Refractory Large B-cell Lymphoma — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | Study Evaluating the Efficacy of KITE-753 Versus Axicabtagene Ciloleucel in Participants With Relapsed or Refr NCT07479797 | Kite, A Gilead Company | Phase 3 |
| Recruiting | Loncastuximab Tesirine and Rituximab as Bridging Therapy Before Standard-of-care CAR-T Therapy in Patients Wit NCT06788964 | University of Utah | Phase 2 |
| Completed | Study of Axicabtagene Ciloleucel Given With Steroids In Participants With Relapsed Or Refractory Large B-Cell NCT05459571 | Kite, A Gilead Company | Phase 2 |